By Josh White
Date: Tuesday 05 May 2026
(Sharecast News) - Pfizer reported stronger-than-expected first-quarter results on Tuesday and reaffirmed its full-year guidance, as growth from older blockbusters and recently launched or acquired medicines offset another sharp fall in Covid product sales.
By Benjamin Chiou
Date: Tuesday 16 Dec 2025
(Sharecast News) - American pharmaceutical giant Pfizer expects revenues and profits to slip slightly in 2026, partly as a result of lost revenues from its Covid-19 products.
By Michele Maatouk
Date: Monday 10 Nov 2025
(Sharecast News) - US biotech firm Metsera tumbled on Monday after it agreed to be bought by Pfizer in a sweetened $10bn deal, with Denmark's Novo Nordisk refraining from making an increased offer.
| Currency | US Dollars |
| Share Price | $ 25.68 |
| Change Today | $ -0.80 |
| % Change | -3.02 % |
| 52 Week High | $28.55 |
| 52 Week Low | $22.02 |
| Volume | 38,903,356 |
| Shares Issued | 5,686m |
| Market Cap | $146,016m |
| RiskGrade | 102 |
| Strong Buy | 4 |
| Buy | 6 |
| Neutral | 16 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 27 |

| Time | Volume / Share Price |
| 16:01 | 3,270,214 @ $25.68 |
| 16:00 | 100 @ $25.67 |
| 16:00 | 329 @ $25.67 |
| 16:00 | 371 @ $25.67 |
| 16:00 | 400 @ $25.67 |
You are here: research